Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Impact of Health-Related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice for Stage I Lung Cancer.

van Dams R, Grogan T, Lee P, Punglia R, Raldow A.

JCO Clin Cancer Inform. 2019 Sep;3:1-8. doi: 10.1200/CCI.19.00072.

2.

Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction.

Punglia RS, Ortiz Pimentel S, Cronin AM, Frank ES, Bellon JR, Abel GA, Uno H, Wong JS.

Breast J. 2019 Sep 8. doi: 10.1111/tbj.13592. [Epub ahead of print] No abstract available.

PMID:
31495035
3.

Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.

Warren LEG, Chen YH, Halasz LM, Brock JE, Capuco A, Punglia RS, Wong JS, Golshan M, Bellon JR.

Breast Cancer Res Treat. 2019 Sep 6. doi: 10.1007/s10549-019-05428-0. [Epub ahead of print]

PMID:
31493031
4.

Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial.

Atkins KM, Truong LT, Rawal B, Chen YH, Catalano PJ, Bellon JR, Punglia RS, Moreau JM, Capuco AT, Hergrueter CA, Chun YS, Wong JS.

Pract Radiat Oncol. 2019 Sep - Oct;9(5):338-346. doi: 10.1016/j.prro.2019.04.009. Epub 2019 May 4.

PMID:
31063823
5.

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS).

Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA.

JNCI Cancer Spectr. 2018 Nov;2(4):pky063. doi: 10.1093/jncics/pky063. Epub 2018 Dec 27.

6.

Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer.

Chang EM, Punglia RS, Steinberg ML, Raldow AC.

Urology. 2019 Apr;126:89-95. doi: 10.1016/j.urology.2018.12.016. Epub 2018 Dec 21.

PMID:
30580007
7.

Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women.

Buscariollo DL, Cronin AM, Borstelmann NA, Punglia RS.

Breast Cancer Res Treat. 2019 Feb;173(3):709-717. doi: 10.1007/s10549-018-5006-5. Epub 2018 Nov 8.

PMID:
30406869
8.

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer.

Muralidhar V, Nipp RD, Mamon HJ, Punglia RS, Hong TS, Ferrone C, Fernandez-Del Castillo C, Parikh A, Nguyen PL, Wo JY.

Ann Surg Oncol. 2018 Dec;25(13):4027-4034. doi: 10.1245/s10434-018-6832-8. Epub 2018 Oct 8.

PMID:
30298331
9.

Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.

Sher DJ, Tishler RB, Pham NL, Punglia RS.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):875-882. doi: 10.1016/j.ijrobp.2018.04.018. Epub 2018 Apr 12.

PMID:
29976499
10.

Estrogen-receptor status and risk of contralateral breast cancer following DCIS.

Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS.

Breast Cancer Res Treat. 2018 Oct;171(3):777-781. doi: 10.1007/s10549-018-4860-5. Epub 2018 Jun 26.

PMID:
29946862
11.

Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.

Grossmith S, Nguyen A, Hu J, Plichta JK, Nakhlis F, Cutone L, Dominici L, Golshan M, Duggan M, Carter K, Rhei E, Barbie T, Calvillo K, Nimbkar S, Bellon J, Wong J, Punglia R, Barry W, King TA.

Ann Surg Oncol. 2018 Nov;25(12):3527-3534. doi: 10.1245/s10434-018-6525-3. Epub 2018 Jun 4.

PMID:
29868979
12.

Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ.

Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS.

J Natl Compr Canc Netw. 2018 Apr;16(4):387-394. doi: 10.6004/jnccn.2018.7003.

PMID:
29632058
13.

Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.

van Ravesteyn NT, van den Broek JJ, Li X, Weedon-Fekjær H, Schechter CB, Alagoz O, Huang X, Weaver DL, Burnside ES, Punglia RS, de Koning HJ, Lee SJ.

Med Decis Making. 2018 Apr;38(1_suppl):126S-139S. doi: 10.1177/0272989X17729358.

14.

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.

Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA.

Breast Cancer Res Treat. 2018 Feb;167(3):751-759. doi: 10.1007/s10549-017-4553-5. Epub 2017 Oct 28.

PMID:
29079937
15.

Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.

Royce TJ, Punglia RS, Chen AB, Patel SA, Thornton KA, Raut CP, Baldini EH.

Ann Surg Oncol. 2017 Oct;24(11):3264-3270. doi: 10.1245/s10434-017-5996-y. Epub 2017 Jul 17.

PMID:
28718037
16.

Nature of Medical Malpractice Claims Against Radiation Oncologists.

Marshall D, Tringale K, Connor M, Punglia R, Recht A, Hattangadi-Gluth J.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):21-30. doi: 10.1016/j.ijrobp.2017.01.022. Epub 2017 Jan 16.

17.

Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.

Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA, Alexander BM, Lin NU, Aizer AA.

JAMA Oncol. 2017 Aug 1;3(8):1069-1077. doi: 10.1001/jamaoncol.2017.0001.

18.

Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.

Wong SM, Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M.

Cancer. 2017 Jul 15;123(14):2609-2617. doi: 10.1002/cncr.30644. Epub 2017 Feb 21.

19.

The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy.

Mihalcik SA, Rawal B, Braunstein LZ, Capuco A, Wong JS, Punglia RS, Bellon JR, Harris JR.

Ann Surg Oncol. 2017 Jul;24(7):1868-1873. doi: 10.1245/s10434-016-5727-9. Epub 2017 Jan 30.

PMID:
28138856
20.

Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.

Braunstein LZ, Taghian AG, Niemierko A, Salama L, Capuco A, Bellon JR, Wong JS, Punglia RS, MacDonald SM, Harris JR.

Breast Cancer Res Treat. 2017 Jan;161(1):173-179. doi: 10.1007/s10549-016-4031-5. Epub 2016 Nov 3.

PMID:
27807809
21.

Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.

Raldow AC, Sher D, Chen AB, Recht A, Punglia RS.

J Clin Oncol. 2016 Nov 20;34(33):3963-3968. doi: 10.1200/JCO.2016.67.8532. Epub 2016 Sep 30.

PMID:
27621393
22.

Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.

Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag D.

JAMA Oncol. 2017 Jan 1;3(1):101-104. doi: 10.1001/jamaoncol.2016.2164.

PMID:
27442038
23.

Reply to comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.

Halasz LM, Uno H, Punglia RS.

Cancer. 2016 Oct 15;122(20):3244-3245. doi: 10.1002/cncr.30187. Epub 2016 Jul 8. No abstract available.

24.

Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.

Halasz LM, Uno H, Hughes M, D'Amico T, Dexter EU, Edge SB, Hayman JA, Niland JC, Otterson GA, Pisters KM, Theriault R, Weeks JC, Punglia RS.

Cancer. 2016 Jul 1;122(13):2091-100. doi: 10.1002/cncr.30009. Epub 2016 Apr 18.

25.

The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.

Decker MR, Trentham-Dietz A, Loconte NK, Neuman HB, Smith MA, Punglia RS, Greenberg CC, Wilke LG.

Ann Surg Oncol. 2016 Sep;23(9):2788-94. doi: 10.1245/s10434-016-5192-5. Epub 2016 Mar 29.

26.

Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.

Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS.

Breast Cancer Res Treat. 2016 Feb;155(3):541-9. doi: 10.1007/s10549-016-3692-4. Epub 2016 Feb 3.

27.

Factors associated with radiation therapy incompletion for patients with early-stage breast cancer.

Freedman RA, Fedewa SA, Punglia RS, Lin CC, Ward EM, Jemal A, Sineshaw HM.

Breast Cancer Res Treat. 2016 Jan;155(1):187-99. doi: 10.1007/s10549-015-3660-4. Epub 2015 Dec 18.

PMID:
26683609
28.

onlineDeCISion.org: a web-based decision aid for DCIS treatment.

Ozanne EM, Schneider KH, Soeteman D, Stout N, Schrag D, Fordis M, Punglia RS.

Breast Cancer Res Treat. 2015 Nov;154(1):181-90.

PMID:
26475704
29.

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.

Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):622-30. doi: 10.1016/j.ijrobp.2015.07.006. Epub 2015 Jul 11.

PMID:
26461004
30.

Medical Malpractice Claims in Radiation Oncology: A Population-Based Study 1985-2012.

Marshall DC, Punglia RS, Fox D, Recht A, Hattangadi-Gluth JA.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):241-50. doi: 10.1016/j.ijrobp.2015.05.040. Epub 2015 Jun 3.

31.

Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer.

Tanguturi SK, Lyatskaya Y, Chen Y, Catalano PJ, Chen MH, Yeo WP, Marques A, Truong L, Yeh M, Orlina L, Wong JS, Punglia RS, Bellon JR.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):358-65. doi: 10.1016/j.prro.2015.06.002. Epub 2015 Jul 28.

PMID:
26231594
32.

Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.

Rose BS, Jiang W, Punglia RS.

Breast Cancer Res Treat. 2015 Jul;152(1):209-216. doi: 10.1007/s10549-015-3451-y. Epub 2015 Jun 4.

PMID:
26041688
33.

Management of older women with early-stage breast cancer.

Punglia RS, Hughes KS, Muss HB.

Am Soc Clin Oncol Educ Book. 2015:48-55. doi: 10.14694/EdBook_AM.2015.35.48.

34.

Management of the regional lymph nodes following breast-conservation therapy for early-stage breast cancer: an evolving paradigm.

Warren LE, Punglia RS, Wong JS, Bellon JR.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):772-7. doi: 10.1016/j.ijrobp.2014.07.006. Epub 2014 Oct 18. Review.

PMID:
25585780
35.

Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.

Braunstein LZ, Niemierko A, Shenouda MN, Truong L, Sadek BT, Abi Raad R, Wong JS, Punglia RS, Taghian AG, Bellon JR.

Breast J. 2015 Mar-Apr;21(2):161-7. doi: 10.1111/tbj.12371. Epub 2015 Jan 6.

PMID:
25559656
36.

Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy.

Mak KS, Chen YH, Catalano PJ, Punglia RS, Wong JS, Truong L, Bellon JR.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1087-95. doi: 10.1016/j.ijrobp.2014.05.021. Epub 2014 Jul 29.

PMID:
25084611
37.

Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.

Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS.

Ann Surg Oncol. 2014 Nov;21(12):3766-73. doi: 10.1245/s10434-014-3802-7. Epub 2014 May 24.

38.

American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing practice improvement.

Vichare A, Eads N, Punglia R, Potters L.

Pract Radiat Oncol. 2013 Apr-Jun;3(2):e37-43. doi: 10.1016/j.prro.2012.09.005. Epub 2012 Oct 24.

PMID:
24674319
39.

Decision analysis and cost-effectiveness analysis for comparative effectiveness research--a primer.

Sher DJ, Punglia RS.

Semin Radiat Oncol. 2014 Jan;24(1):14-24. doi: 10.1016/j.semradonc.2013.08.002. Review.

PMID:
24314338
40.

Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?

Punglia RS, Schnitt SJ, Weeks JC.

J Natl Cancer Inst. 2013 Oct 16;105(20):1527-33. doi: 10.1093/jnci/djt256. Epub 2013 Sep 25.

PMID:
24068769
41.

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.

Ruddy KJ, Desantis SD, Gelman RS, Wu AH, Punglia RS, Mayer EL, Tolaney SM, Winer EP, Partridge AH, Burstein HJ.

Breast Cancer Res Treat. 2013 Oct;141(3):421-7. doi: 10.1007/s10549-013-2700-1. Epub 2013 Sep 24.

PMID:
24062210
42.

Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.

Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR.

Breast Cancer Res Treat. 2013 Jul;140(2):353-61. doi: 10.1007/s10549-013-2627-6. Epub 2013 Jul 9.

PMID:
23836011
43.

Modeling the effectiveness of initial management strategies for ductal carcinoma in situ.

Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS.

J Natl Cancer Inst. 2013 Jun 5;105(11):774-81. doi: 10.1093/jnci/djt096. Epub 2013 May 3.

44.
45.

Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer.

Sher DJ, Parikh RB, Mays-Jackson S, Punglia RS.

Am J Clin Oncol. 2014 Jun;37(3):215-21. doi: 10.1097/COC.0b013e31827a7d2a.

PMID:
23275277
46.

Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.

Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):e109-16. doi: 10.1016/j.ijrobp.2012.08.007. Epub 2012 Oct 9.

47.

Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.

Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):948-52. doi: 10.1016/j.ijrobp.2012.07.2377. Epub 2012 Sep 11.

PMID:
22975615
48.

Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.

Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ.

Cancer. 2012 Dec 15;118(24):6022-30. doi: 10.1002/cncr.27691. Epub 2012 Jun 6.

49.

Should a sentinel node biopsy be performed in patients with high-risk breast cancer?

Westover KD, Westover MB, Winer EP, Richardson AL, Iglehart JD, Punglia RS.

Int J Breast Cancer. 2011;2011:973245. doi: 10.4061/2011/973245. Epub 2011 Aug 10.

50.

Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.

Halasz LM, Sreedhara M, Chen YH, Bellon JR, Punglia RS, Wong JS, Harris JR, Brock JE.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e581-6. doi: 10.1016/j.ijrobp.2011.08.015. Epub 2011 Dec 28.

PMID:
22208975

Supplemental Content

Loading ...
Support Center